Joseph A Trapani Selected Research

Food Coloring Agents

1/2022

IFN-γ+ cytotoxic CD4+ T lymphocytes are involved in the pathogenesis of colitis induced by IL-23 and the food colorant Red 40.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joseph A Trapani Research Topics

Disease

54	Neoplasms (Cancer) 04/2022 - 03/2002
5	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 02/2012 - 09/2004
4	Infections 01/2020 - 02/2007
4	Virus Diseases (Viral Diseases) 01/2019 - 04/2010
4	Leukemia 05/2017 - 03/2003
3	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 12/2013
3	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2017 - 02/2015
3	Lymphoma (Lymphomas) 12/2008 - 07/2002
2	Multiple Myeloma 06/2022 - 02/2011
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 11/2013
2	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 09/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2017 - 01/2012
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2017 - 07/2014
2	Breast Neoplasms (Breast Cancer) 01/2017 - 08/2004
2	Inflammation (Inflammations) 08/2010 - 05/2010
2	Carcinoma (Carcinomatosis) 04/2009 - 11/2002
2	Neoplasm Metastasis (Metastasis) 11/2005 - 11/2002
1	Colitis 01/2022
1	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2022
1	COVID-19 12/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Metaplasia 01/2018
1	Gastritis 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 12/2017
1	Triple Negative Breast Neoplasms 01/2017
1	Cytokine Release Syndrome 09/2015

Drug/Important Bio-Agent (IBA)

22	PerforinIBA 01/2019 - 03/2002
17	Granzymes (Granzyme)IBA 01/2021 - 03/2002
12	AntigensIBA 01/2020 - 11/2002
11	Chimeric Antigen ReceptorsIBA 09/2021 - 11/2013
11	Proteins (Proteins, Gene)FDA Link 10/2020 - 09/2004
10	CytokinesIBA 01/2022 - 07/2002
6	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2020
5	AutoantigensIBA 05/2017 - 11/2002
4	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2020
3	EnzymesIBA 01/2022 - 04/2009
3	Peptides (Polypeptides)IBA 01/2021 - 11/2002
3	Messenger RNA (mRNA)IBA 10/2020 - 01/2014
3	LigandsIBA 01/2017 - 11/2002
2	Lenalidomide (CC 5013)FDA Link 06/2022 - 02/2011
2	InterleukinsIBA 01/2022 - 07/2002
2	Serine Proteases (Serine Protease)IBA 01/2020 - 10/2003
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 03/2012
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 11/2005
2	EpitopesIBA 01/2020 - 05/2017
2	VaccinesIBA 01/2020 - 05/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 12/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 07/2002
2	InterferonsIBA 01/2018 - 07/2002
2	Interleukin-2 (IL2)IBA 05/2017 - 12/2007
2	Histone Deacetylase InhibitorsIBA 01/2017 - 08/2003
2	Trastuzumab (Herceptin)FDA Link 01/2017 - 08/2004
2	Cathepsin CIBA 05/2011 - 02/2007
2	CarbohydratesIBA 04/2009 - 12/2005
2	chenodeoxycholate sulfate conjugate (CDCS)IBA 09/2008 - 09/2007
2	CaspasesIBA 10/2003 - 03/2003
2	Single-Chain AntibodiesIBA 11/2002 - 11/2002
2	Interferon-gamma (Interferon, gamma)IBA 11/2002 - 07/2002
1	elotuzumabIBA 06/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Food Coloring AgentsIBA 01/2022
1	Interleukin-23 (Interleukin 23)IBA 01/2022
1	ChromatinIBA 01/2022
1	CholesterolIBA 01/2022
1	Bispecific AntibodiesIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	poliovirus receptorIBA 12/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	SugarsIBA 01/2021
1	Death Domain ReceptorsIBA 10/2020
1	Copper Transporter 1IBA 10/2020
1	B7-H1 AntigenIBA 10/2020
1	Blocking AntibodiesIBA 10/2020
1	Chelating AgentsIBA 10/2020
1	CopperIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	ibrutinibIBA 01/2020
1	Cancer VaccinesIBA 01/2020
1	zanubrutinibIBA 01/2020
1	Cysteamine (Mercaptamine)FDA Link 01/2018
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2018
1	DioxygenasesIBA 01/2018
1	NucleotidesIBA 12/2017
1	Interferon Type IIBA 12/2017
1	Chemokine ReceptorsIBA 05/2017
1	Adenosine (Adenocard)FDA LinkGeneric 03/2017
1	AntibodiesIBA 01/2017
1	PanobinostatIBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	Cytostatic AgentsIBA 01/2017

Therapy/Procedure

22	Therapeutics 01/2022 - 08/2004
21	Immunotherapy 04/2022 - 11/2002
3	Drug Therapy (Chemotherapy) 11/2021 - 08/2003
3	Ligation 05/2015 - 11/2005
2	Radiotherapy 11/2021 - 01/2017